baber/WOPTO huggingface dataset:
Patent IE-44048-L (IE)
Title: Separating albumin from proteins.
IPC: A61K35/14
Filed: 1976-12-10
Abstract: The production of albumin for non-therapeutic applications from a suspension obtained from blood plasma is carried out by flotation filtration of the suspension on a fabric filter element. The non-albumin-containing constituents of the emulsion are collected on the fabric filter element and a clear albumin solution is obtained as the filtrate. The process enables the separation of heat-precipitated proteins from the suspension with a substantially smaller outlay compared with known filtration processes, within a shorter filtration time and avoiding a blockage of the filter inserts.
[GB1569168A]
Patent IE-822756-L (IE)
Title: Balanced pressure coupling apparatus
IPC: F17C13/04
Filed: 1982-11-19
Abstract: A coupler adaptor (32) is provided for use in operative association with a container (16) and a valve (26). The container houses relatively high pressurised carbon dioxide gas for use in carbonating a beverage. The valve is actuated in order to release the gas to an interface passage (52) formed in the coupler adaptor. The coupler adaptor has a pair of grooves (54, 56) formed on opposite sides of the interface passage for receiving O-rings (58, 60). The coupler adaptor is also in operative association with a pressure regulator (62). The pressurised gas enters the pressure regulator from the coupler adaptor interface passage. The coupler adaptor remains operatively joined to the pressure regulator without retaining structure due to the balanced gas pressure which results because of the O-rings positioned adjacent the coupler adaptor interface passage.
Patent IE-44243-L (IE)
Title: Hard foam polyvinyl chloride materials
IPC: C08J9/36
Filed: 1976-12-23
Abstract: 1510050 Foaming temporary plasticized polyvinyl chloride LONZA Ltd 30 Dec 1976 [9 Jan 1976] 54299/76 Heading C3C A hard foamed polyvinyl chloride is made by heating a mixture of polyvinyl chloride, a blowing agent and a temporary plasticizer which is a polymerizable monomer having at least one ethylenically unsaturated double bond under pressure in a pressure mould cooling the mixture, removing the formed body from the mould, expanding the body by heating and then polymerizing the monomer, after completion of the expansion, by means of ionizing radiation which is U.V. rays, X-rays, gamma-rays, #-particles or accelerated electron beams. The monomer may be a C1-8 alkyl or a glycol ester of acrylic, methacrylic or maleic acid. In the example a mixture of polyvinyl chloride, calcium carbonate dibasic lead phthalate, ammonium bicarbonate and methyl methacrylate was heated under pressure in a mould, cooled and expanded in a drying cabinet and the foamed body was then treated with electrons to polymerize the methacrylate.
[GB1510050A]
Patent IE-853107-L (IE)
Title: Theophylline sustained release formulation
IPC: A61K9/50
Filed: 1985-12-10
Abstract: A sustained-release theophylline formulation, which comprises matrix pellets in which theophylline particles are embedded in a matrix of water-insoluble plastic and which are enclosed by a membrane of water-insoluble plastic containing embedded particles of lactose, produces and maintains plasma theophylline levels within the therapeutic range.
[US4803080A]
Patent IE-893764-L (IE)
Title: Method of forming shaped hydrogel articles including contact¹lenses
IPC: C08F220/28
Filed: 1989-11-24
Abstract: Shaped hydrogel articles such as soft contact lenses are prepared by (1) molding or casting a polymerization mixture comprising: (a) a monomer mixture comprising a major proportion of a hydrophilic (meth)acrylate ester such as 2-hydroxyethyl methacrylate, and a cross-linking monomer; and (b) a water-displaceable diluent, wherein said diluent has a viscosity of at least 100 MPa Sec at 30 DEG C, and wherein said diluent consists essentially of a boric acid ester of certain dihydric alcohols, said dihydric alcohols having Hansen polar ( delta p) and Hansen hydrogen bonding ( delta h) cohesion parameters falling within the area of a circle defined as having a center at delta h = 20.5,  delta p = 13, and a radius of 8.5, to produce a shaped gel of a copolymer of said monomers and said diluent, and (2) thereafter replacing said diluent with water.
Patent NO-822612-L (NO)
Inventor: KARDYS JOSEPH ANTHONY
IPC: A61K/
Filed: 1982-07-30
Abstract: A novel compound of empirical formula  C9H7N2O5SRR<1>Z (I)  produced by reacting an ester of the formula <CHEM> with an equimolar amount of an amine of the formula ZNH2 in a reaction inert organic solvent at a temperature of from about 0 to 110 DEG C wherein R is hydrogen benzyl or (C1-C3) alkyl; R<1> is benzyl or (C1-C4) alkyl and Z is benzopyronyl, alkyl substituted benzopyronyl, 2-pyridyl, alkyl substituted-2-pyridyl, 2-thiazolyl, 2-thiazolyl substituted by one or two alkyl group, or 5-alkyl-3-isoxazolyl, each alkyl having from one to four carbon atoms; and a novel process utilizing the compounds of formula (I) as intermediates for production of known anti-inflammatory agents of the formula <CHEM> u
Patent NO-824040-L (NO)
Inventor: BERTIN JEAN
IPC: C07D471/16
Filed: 1982-12-02
Abstract: Compounds of the formula:   <IMAGE>   wherein R1 represents hydrogen, chlorine or methoxy, R2 represents hydrogen, methyl or benzyl, and R3 and R4 represent hydrogen, or R3 represents methyl and R4 represents hydrogen or R3 represents hydrogen and R4 represents methyl, are new compounds useful in therapy as they possess an antianoxic activity.
Patent NO-831293-L (NO)
Inventor: PHILLIPS BRINLEY MORRIS
IPC: C11D1/75
Filed: 1983-04-12
Abstract: Concentrated surfactant compositions comprise a mixture of an amine oxide with from 4 to 40%, by weight of the active content of the mixture, of an anionic surfactant, optionally up to 10% by weight of an electrolyte, and sufficient water to maintain the mixture in the G phase.
Patent NO-841295-L (NO)
Inventor: SCHMIDT WILLI
IPC: B28B3/20
Filed: 1984-04-02
Abstract: A press for the preparation of raw plastic material blanks is described. It has a feed device connected to a rotor housing in which a circular rotor is eccentrically supported for the generation of pressure and the transport of the material. Rotor housing and rotor form a tapering channel. The circular rotor has at least one axially extending material transport ridge forcibly guided along a guide rail located in the rotor housing. At its smaller end the tapering channel forms an extrusion gap which opens into an outlet opening for the plastic material, to which a nozzle is attached.
Patent NO-841972-L (NO)
Inventor: KUKES SIMON GREGORY
IPC: C10G45/04
Filed: 1984-05-16
Abstract: Metals contained in a hydrocarbon containing feed stream are removed by contacting the hydrocarbon containing feed stream under suitable demetallization conditions with hydrogen and a catalyst composition comprising zirconium phosphate and chromium phosphate. The life and activity of the catalyst composition may be increased by introducing a decomposable metal compound selected from the group consisting of the metals of Group V-B, Group VI-B, Group VII-B and Group VIII of the Periodic Table into the hydrocarbon containing feed stream prior to contacting the hydrocarbon containing feed stream with the catalyst composition.
Patent NO-852355-L (NO)
Inventor: GOUPIL JEAN-JACQUES
IPC: A61Q11/00
Filed: 1985-06-11
Abstract: Compositions for the hygienic care and health of teeth and of the periodontal tissue of gums, provided as a paste, a gel or any other appropriate form, characterized in that they contain an association of fluorined salts having a concentration of fluorine ions comprised between 200 mg and 2.000 mg for 100 g of composition, in other words comprised between 2.000 and 20.000 ppm, the fluorine ion concentration being preferably comprised between 250 and 1.000 mg per 100 g of composition, that is between 2.500 and 10.000 ppm, xylitol with a concentration comprised between 5 and 50% by weight calculated with respect to the final composition, and preferably comprised between 10 and 25%, in an appropriate excipient.
Patent NO-864751-L (NO)
Inventor: PREVOTAT BERNARD
IPC: B29C48/09
Filed: 1986-11-26
Abstract: A central body portion has first, second and third concentric cylinders of successively increasing diameter encircling the central body portion and each other in spaced relationship to form three concentric annular spaces for receiving molten material. Only one end of each of the first, second and third cylinders and the body portion are rigidly attached to each other so as to maintain the rigid spaced relationship. A mandrel is attached to the outer end of the central body portion and a die is attached to the outer end of the outer most concentric cylinder in spaced relationship to the mandrel to shape the molten material into a pipe having a multi-layered wall.
Patent NO-872659-L (NO)
Inventor: FRANCIS DANIEL LEE
IPC: A61K47/36
Filed: 1987-06-25
Abstract: An improved pharmaceutical or veterinary composition contains galactitol as carrier for the therapeutic agent. Preferred therapeutic agents include anti-infective and anti-cancer drugs, preferably cytotoxic agents and lymphokines. One example is a lyophilized composition of about 20 parts by weight of cyclophosphamide, taken as the anhydride, about 5 to 21 parts by weight of galactitol as excipient, and about 1.4 to 3 parts by weight of water. Preferably, the amount of galactitol is 15-21 parts by weight. The galactitol enhances the chemical and physical stability of the drug and allows faster reconstitution of the formulation in water than mannitol.
Patent NO-883260-L (NO)
Inventor: CERCEK BORIS
IPC: G01N33/50
Filed: 1988-07-22
Abstract: The method of the present invention comprises contacting a suspension of viable lymphocytes with a solution containing a membrane potential sensitive fluorescent dye. The contact between the lymphocyte suspension and the MPS dye is maintained for sufficient time to permit labelling of the lymphocytes by the MPS dye material. The labelled lymphocytes are passed individually through a focused source of excitation energy causing any MPS dye material to fluoresce. The fluorescent emission from each cell is recorded as a pulse and the number of pulses of each intensity are recorded. The distribution of the number of pulses versus the intensity is prepared distribution is bimodal. A first peak includes pulses of low fluorescence intensity and a second peak comprises pulses of high fluorescence intensity. A ratio of the total counts of low fluorescence intensity to the total counts of high fluorescence intensity produces a factor which distinguishes lymphocytes derived from bodies afflicted with malignancy from bodies which are not afflicted with malignancy.
Patent NO-884701-L (NO)
Title: Fosforfrie detergent-blekings-blandinger.
Inventor: EMERY WILLIAM DEREK
IPC: C11D3/39
Filed: 1988-10-21
Abstract: Fosfatfrie, aluminiumsilikatbygde vaske/blekepreparater med virkelig effektiv rense- og flekkfjerningsevne ved lave vasketemperaturer på0°C og lavere, hvilke preparater omfatter minst ett vaskeaktivt materiale, fra 15 til ca.0 vekt* av et vannuløselig aluminiumsilikat-kationebyttermateriale, fra 0,5 til ca.vekt% av en polyfosfonatforbindelse og fra ca. 1 til ca. 15 vekt% av en fast organisk peroksysyreforbindelse som hoved-blekemiddel, idet preparatet er hovedsakelig fritt for ytterligere byggematerialer valgt fra gruppen bestående av citronsyre og dens alkalimetallsalter, bikarbonater, nitriltri-acetater og blandinger av disse. Ved en foretrukket utførelses-form inneholder preparatet videre et enzym, spesielt et proteo-lytisk enzym.
Patent NO-890935-L (NO)
Inventor: RAJALA VELI-MATTI
IPC: D21D5/02
Filed: 1989-03-06
Abstract: The invention relates to a device for screening pulp, comprising a screen drum (2) provided with holes for the passage of an accepted pulp fraction therethrough; and a blade (10) for a screening device. The device comprises straight blades (10) wiping the surface of the screen drum (2) and extending in parallel with the axis of the screen drum (2). Reject which does not pass through the screen drum (2) is removed through a reject discharge opening (5) at the other end of the screen drum. For transferring the reject from the surface of the screen drum (2) to the reject discharge end, the surface of the blades (10) is on the screen drum side provided with grooves (11) so inclined that the front end of the groove (11) is closer to the pulp input than the backward end of the same groove (11). Thereby each groove (11) in the blades (10) causes the reject to be transferred towards the reject discharge opening (5).
Patent NO-923191-L (NO)
Inventor: MICHEL HELMUT
IPC: C07D207/28
Filed: 1992-08-14
Abstract: The invention concerns nitric acid esters of cyclohexanol of formula I    <IMAGE>  (I)  in which A signifies a valency bond or a C1-C6-alkylene chain and B the group -NR1-CO-Z, -NR1-SO2-Z or -CO-NR2-Z, whereby R1 signifies hydrogen or a C1-C6-alkyl alkyl group R2 hydrogen, a hydroxyl, hydroxy-C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl group and Z signifies hydrogen a C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl group which may optionally be substituted for the case that B is an -NR1-CO-Z group, Z can also signify a C1-C6-alkoxy group.
Patent NO-924372-L (NO)
Title: Anordning for kontrollert avgivelse
Inventor: CHOPRA SHAM KUMAR
IPC: A61K31/435
Filed: 1992-11-12
Abstract: Denne oppfinnelse vedrører en anordning for avgivelse av minst en aktiv substans (f.eks. ranitidin) til et fluid medium ved opplesning, omfattende et belegg som er ugjennomtrengelig for den aktive substans og fluidet, som har minst en åpning deri og som definerer et dannet hulrom, og at hulrommet er fylt med en formet kjerne omfattende den aktive substans, og hvori: a) en overflate av kjernen blir eksponert ved eksponering av anordningen for det fluide medium, og opplesning av overflaten ved det fluide medium forårsaker en forandring i minst en dimensjon av overflatearealet, mens overflatearealet av den eksponerte overflate holder seg i alt vesentlig konstant over minst 50% av den samlede opplesningstid for kjernen; eller b) den aktive substans er fordelt i en matriks av en inert uleselig eksipient, anordningen er aksielt symmetrisk med sin åpning plassert i periferien slik at kjernens avgivelses- overflate som eksponeres gjennom åpningen er i alt vesentlig sylindrisk eller del av en sylinder i form, hvorved det tilla- tes i alt vesentlig konstant avgivelse av den aktive substans over minst en del av opplesningstiden; og fremgangsmåter for dens fremstilling.
Patent NO-931769-L (NO)
Inventor: MOCK ELMAR
IPC: B29C45/16
Filed: 1993-05-14
Abstract: PCT No. PCT/CH92/00188 Sec. 371 Date May 14, 1993 Sec. 102(e) Date May 14, 1993 PCT Filed Sep. 11, 1992 PCT Pub. No. WO93/05945 PCT Pub. Date Apr. 1, 1993.A closure unit for a container for storing and handling flowable products is made from at least two different thermoplastic materials, the different materials fulfilling different functions. A basic thermoplastic material (A.2) is used for sealing against the container (G.2), and an area made of another different thermoplastic material (B.2,C) is provided to fulfill additional sealing functions, to increase mechanical stability, to have a reduced permeability, and to provide increased elasticity for additional opening and closing and/or absorption characteristics. The closure unit is produced by a multimaterial injection molding process, so that contact surfaces between the different thermoplastic materials can be interconnected by reversible or irreversible positive engagement and/or by more or less pronounced melting into one another. The closure unit is in two parts and comprises a pouring part (1.2) and a closure part (2.2), or is in one part. The two-part closure unit is produced in a single operation in a closed state.
Patent NO-940080-L (NO)
Title: Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav
Inventor: ALBERT RAINER
IPC: A61K51/08
Filed: 1994-01-10
Abstract: Oppfinnelsen omhandler somatostatinpeptider som bærer en chelaterende gruppe valgt fra en bi funksjonell N4-chelaterende gruppe som særlig er egnet for merking med Te, Rh, Cu, Co eller Re, og en bifunksjonell polyaminopolykarboksylsyre- chelaterende gruppe. Peptidene er kompleksdannet med et a-, P_; Y_ eller positronemitterende nuklid eller et nuklid med Auger-e~-kaskader og de er anvendbare som radiofarmasøytika.
Patent NO-942942-L (NO)
Title: Akryl kopolymermembraner for biosensorer
Inventor: ALLEN DOUGLAS J
IPC: B01D71/40
Filed: 1994-08-08
Abstract: Det er beskrevet homogene membraner (20) som er sammensatt av akrylkopolymerer og som er Istand til å absorbere 105& til 50* av sin tørrvekt med vann. Kopolymerene Innbefatter en hydrofil komponent som Innbefatter akrylestere med en poly(etylénoksid) substltuent som endel av alkoholgruppen. Kopolyerene Innbefatter ytterligere metakrylat og/eller akrylat- monomerenheter. Membranene (20) er anvendelige ved fremstillingen av biosensorer, for eksempel en glukosesensor (10) ment for In vlvo bruk. Variasjoner l forholdene mellom de monomere komponentene gjør det mulig å fremstille membraner som har varierende permeabiliteter.
Patent NO-951619-L (NO)
Inventor: JAECKLIN FELIX PAUL
IPC: E02D17/20
Filed: 1995-04-27
Abstract: PCT No. PCT/EP94/02907 Sec. 371 Date Oct. 6, 1995 Sec. 102(e) Date Oct. 6, 1995 PCT Filed Sep. 1, 1994 PCT Pub. No. WO95/06783 PCT Pub. Date Mar. 9, 1995A construction element, such as a supporting element for a retaining wall, has a casing which is at least partially permeable. The casing contains a block-shaped, granulated, bulk or porous filling material. The casing has two layers including a relatively rigid grating part (GT) for strength and a relatively flexible, finer meshed netting part (NT) for containment of filling material. The casing is designed as a closed hollow body which is coupled to the filling (FL) so as to form a substantially self-supporting construction element which is completely prefabricated.
Patent NO-951894-L (NO)
Inventor: WIDLUND URBAN
IPC: D04H1/70
Filed: 1995-05-12
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent NO-962749-L (NO)
Inventor: BAKER RAYMOND
IPC: A61P25/06
Filed: 1996-06-28
Abstract: The present invention relates to compounds of the formula (I): <CHEM> wherein R<1> is hydrogen, halogen, C1-6alkyl, C1-6alkoxy, CF3, NO2, CN, SR<a>, SOR<a>, SO2R<a>, CO2R<a>, CONR<a>R<b>, C2-6alkenyl, C2-6alkynyl or C1-4alkyl substituted by C1-4alkoxy, where R<a> and R<b> are hydrogen or C1-4alkyl; R<2> is hydrogen, halogen, C1-6alkyl, C1-6alkoxy substituted by C1-4alkoxy or CF3; R<3> is hydrogen, halogen or CF3; R<4> is selected from the definitions of R<1>; R<5> is selected from the definitions of R<2>; R<6> is a 5-membered or 6-membered heterocyclic ring containing 2 or 3 nitrogen atoms optionally substituted by =O or =S and optionally substituted by an aminoalkyl group; R<9a> and R<9b> are hydrogen or C1-4alkyl, or R<9a> and R<9b> are joined to form a C5-7 ring; X is C1-4alkylene optionally substituted by oxo; and Y is a C1-4alkyl group substituted by hydroxyl; and pharmaceutically acceptable salts and prodrugs thereof. <??>The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.
Patent NO-981402-L (NO)
Title: FremgangsmÕte og blanding for kontrollering av begroing ved bruk av fettsyreestere av polyglykol
Inventor: GLOVER DANIEL E
IPC: A01N37/02
Filed: 1998-03-27
Abstract: Foreliggende oppfinnelse omhandler en fremgangsmåte for å hemme bakterier i å adhere til en senkbar overflate. Fremgangsmåten omfatter påføring på den senkbare overflaten av en effektiv menge av minst en fettsyreester av polyglykol for å hemme bakteriell adhesjon til den senkbare overflaten. Fore- liggende oppfinnelse omhandler også en fremgangsmåte for å kontrollere begroing av et vandig system. Denne fremgangsmåten tilsetter en effektiv mengde av minst en fettsyreester av polyglykol for å hemme bakterier i å adhere til en senket overflate i det vandige systemet. Denne fremgangsmåten sørger for en effektiv kontroll av begroing, uten å drepe de forurensende organismene i vesentlig grad. Den foreliggende oppfinnelsen omhandler også en blanding som inneholder fettsyreestere av polyglykol og er anvendelig i de ovenfor nevnte fremgangsmåter. Blandingene omfatter minst en fettsyreester av polyglykol i en mengde som effektivt hemmer bakterier i å adhere til senkbare eller senkede overflater.
Patent NO-982721-L (NO)
Inventor: STEEN STIG
IPC: A01N1/02
Filed: 1998-06-12
Abstract: A preservation solution intended for organs and tissues or parts thereof from humans and animals and containing calcium and nitroglycerine is described. Moreover, the use of such a preservation solution and a method for preserving organs and tissues or parts thereof from humans and animals in such a preservation solution are described.
Patent NO-983295-L (NO)
Inventor: HANSSON HANS-ARNE
IPC: A61K45/00
Filed: 1998-07-16
Abstract: There is provided the use of a thrombin inhibitor in the manufacture of a product for use in the control of wound healing processes within the body, in particular, the inhibition or prevention of fibrin-related adhesion and/or scar tissue formation, as well as products for use in the control of wound healing processes within the body comprising polysaccharides (e.g., chitosans) and low molecular weight peptide-based thrombin inhibitors.
Patent NO-986037-L (NO)
Inventor: SCHINDLER SIGRAM
IPC: H04Q11/04
Filed: 1998-12-22
Abstract: The signalization method uses a least cost router (3) coupled to the ISDN terminal and responding to a received signalization command call reference and an ISDN subscriber identification (TEE) for providing a modified signalization command transmitted to the telecommunications network exchange (V). An independent claim for a device for modification of the signalization command transmitted between an ISDN subscriber and a telecommunications network exchange is also provided.
Patent NO-993083-L (NO)
Inventor: BUCH-RASMUSSEN THOMAS
IPC: A61J1/00
Filed: 1999-06-22
Abstract: A medicaments, container for storing a liquid medicament comprising one or more active medicaments, water and at least one preservative has a preferably cylindrical wall defining an interior space for such liquid medicament. The wall includes at least two opposed portions composed of a polymer material with a thickness of between 0.3 mm and 3 mm, a light transmission at 400 nm of 25% or more measured through the opposed container wall portions when the container is filled with water, using a standard spectrophotometer and air as reference. The polymer wall portions are of a material comprising at least 70% by weight of a linear optionally branched polyolefin material, the olefin monomer being selected from ethylene, propylene, butylene or a mixture thereof The polyolefin material has a crystallinity above 35% by weight, measured by differential scanning calorimetry, by cutting pieces from the container walls and heating them in an aluminum pan from 10 DEG  C. to 270 DEG  C. at the scanning rate of 10 DEG  C./min, recording and integrating the melting endotherms, and using the value of 209 J/g for 100% crystalline polypropylene as a reference.